Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q4 FY26

Par Drugs & Chemicals Q4 FY26 Results: Net Profit ₹0.9 Cr, Down 47.1% YoY

Par Drugs & Chemicals Ltd reported revenue from operations of ₹19.6 Cr (-12.1% YoY) and net profit of ₹0.9 Cr (-47.1% YoY) for Q4 FY26.

Q4 FY26 at a glance · ₹ crore
MetricQ4 FY26Q3 FY26Q4 FY25
Revenue from operations19.629.322.3
Other income0.41.30.8
Total income20.030.723.1
Profit before exceptional items & tax0.86.42.3
Profit before tax0.86.42.3
Net profit0.94.81.7
Operating margin4.0%20.8%10.0%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year-47.10%
Net profit, quarter on quarter-81.20%
Revenue, year on year-12.10%
Source

NSE results filing, NSE: PAR. Figures extracted from the filing.

Read the filing ↗

Par Drugs & Chemicals Ltd: key numbers

Share price
₹131.41
Market cap
₹161.7 Cr
Revenue (annual)
₹103.7 Cr
Net profit (annual)
₹13.11 Cr
P/E (TTM)
11.2×Sector 50.4×
Promoter holding
73.41%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Par Drugs & Chemicals Ltd

All →
13:27 IST NSE
Management Change

Par Drugs & Chemicals Management Change

Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.

14:54 IST NSE
Annual General Meeting

Par Drugs & Chemicals Annual General Meeting

Par Drugs and Chemicals Limited held its 27th Annual General Meeting on September 26, 2026. Management reviewed the company's financial performance and business affairs during the session.